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Aim To evaluate the clinical pharmacist-led medication 
reconciliation process in clinical practice by quantifying 
and analyzing unintentional medication discrepancies at 
hospital admission.
Methods An observational prospective study was con-
ducted at the Clinical Department of Internal Medicine, 
University Hospital Dubrava, during a 1-year period (Octo-
ber 2014 – September 2015) as a part of the implemen-
tation of Safe Clinical Practice, Medication Reconciliation 
of the European Network for Patient Safety and Quality of 
Care Joint Action (PASQ JA) project. Patients older than 18 
years taking at least one regular prescription medication 
were eligible for inclusion. Discrepancies between pharma-
cists’ Best Possible Medication History (BPMH) and physi-
cians’ admission orders were detected and communicated 
directly to the physicians to clarify whether the observed 
changes in therapy were intentional or unintentional. All 
discrepancies were discussed by an expert panel and clas-
sified according to their potential to cause harm.
Results In 411 patients included in the study, 1200 medi-
cation discrepancies were identified, with 202 (16.8%) be-
ing unintentional. One or more unintentional medication 
discrepancy was found in 148 (35%) patients. The most fre-
quent type of unintentional medication discrepancy was 
drug omission (63.9%) followed by an incorrect dose (24.2%). 
More than half (59.9%) of the identified unintentional medi-
cation discrepancies had the potential to cause moderate to 
severe discomfort or clinical deterioration in the patient.
Conclusion Around 60% of medication errors were as-
sessed as having the potential to threaten the patient safe-
ty. Clinical pharmacist-led medication reconciliation was 
shown to be an important tool in detecting medication 
discrepancies and preventing adverse patient outcomes. 
This standardized medication reconciliation process may 
be widely applicable to other health care organizations 
and clinical settings.
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Medication reconciliation is designated as “the process 
of identifying the most accurate list of a patient’s current 
medicines including the name, dosage, frequency, route 
and comparing them to the current list in use, recognizing 
any discrepancies, and documenting any changes, thus re-
sulting in a complete list of medications, accurately com-
municated” (1). This definition described by the Institute for 
Healthcare Improvement highlights the need for accuracy 
in obtaining the Best Possible Medication History (BPMH), 
ie, a comprehensive list of all home medications taken by 
the patient prior to hospital admission (2). Moreover, if the 
goal is to prevent inappropriate or interrupted drug thera-
py during hospitalization, the most accurate and complete 
BPMH needs to be recorded at the time of admission and 
appropriately transferred in the process of care.
Review of the literature disclosed ample evidence showing 
the occurrence of medication discrepancies between the 
BPMH and physicians’ admission medication orders and re-
vealed a high incidence of medication discrepancies (3-9). 
According to the systematic literature review, 27%-54% of 
the patients had at least one medication history discrepan-
cy at hospital admission, with 19%-75% of these being un-
intentional (10), thus carrying a huge potential to adversely 
affect patient safety (3,4,6,8). Many studies have demon-
strated the positive effect of medication reconciliation on 
identifying and rectifying medication errors at the time of 
admission (3,11-15). Most of them involved pharmacists, 
who have been shown to be more thorough than other 
health care professionals in obtaining a complete medi-
cation history (16-18). A recent meta-analysis confirmed 
that pharmacy-led medication reconciliation interventions 
were an effective strategy in reducing medication discrep-
ancies and had a greater impact when conducted at either 
admission or discharge (19). Moreover, such interventions 
were proven to be cost-effective (20,21).
The process of medication reconciliation has been advo-
cated by many patient safety organizations and authorities 
trying to facilitate its implementation (22-25). In 2006, the 
World Health Organization (WHO) launched the High 5s 
Project with an aim of reducing patient safety problems 
by implementing and evaluating Standard Operating Pro-
cedures (SOPs) across countries (24). “Medication Accuracy 
at Transitions in Care”, or Medication Reconciliation, was 
one of the fully developed SOPs. It was considered im-
portant to determine the feasibility of its implementation 
and to measure the impact on patient safety in different 
health care environments. To help establish consistency in 
a range of health care systems, the WHO High 5s Protocol 
on Medication Reconciliation and Implementation Guide 
was published in 2015 (26).
The implementation of medication reconciliation in Croa-
tia has been initiated within the scope of the Work Pack-
age 5 of the European Union Network for Patient Safety 
and Quality of Care (PaSQ) project (27), which was adapt-
ed from the original WHO High 5s Protocol on Medication 
Reconciliation and Implementation Guide. The goal of this 
project was to initiate the implementation of safe clinical 
practice, including medication reconciliation, across Cro-
atian hospitals and to collect and report the data on its 
impact on patient safety. Since 2014, University Hospital 
Dubrava, Zagreb, has been participating in the implemen-
tation of medication reconciliation project activities sup-
ported by the Croatian PaSQ National Contact Point (NCP), 
Agency for Quality and Accreditation in Healthcare and So-
cial Welfare.
The primary aim of this study was to evaluate the process 
of clinical pharmacist-led medication reconciliation imple-
mentation in clinical practice by quantifying and analyz-
ing unintentional medication discrepancies at hospital 
admission. The secondary aim was to investigate possible 




This prospective, observational study was conducted at the 
Clinical Department of Internal Medicine, University Hospi-
tal Dubrava, Zagreb, a 600-bed teaching hospital during a 
1-year period from October 2014 to September 2015. All 
patients included in the study were randomly selected, us-
ing a computer-generated random number table, upon 
admission to the hospital after the routine primary medi-
cation history had been taken. Patients were considered 
eligible for the study if they were aged 18 years and older 
and taking at least one regular prescription medication. Pa-
tients were excluded if they were not able to answer the 
questions needed to complete the structured interview, 
did not have a caregiver who could be interviewed in case 
the patient was unable to participate in the interview, were 
unable or unwilling to give their consent, or were trans-
ferred from another ward. Ethical approval of the study 
was obtained from the Hospital Ethics Committee and 
all patients gave their written informed consent before 
taking part in the study.
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Medication reconciliation process
Medication reconciliation process was based on the WHO 
Standard Operating Protocol and Implementation Guide 
adapted from the original WHO High 5s Protocol on Medi-
cation Reconciliation and Implementation Guide (26). To 
standardize the process of data collection and medication 
reconciliation, two clinical pharmacists, formally trained by 
the PASQ Croatia NCP, conducted the medication reconcili-
ation process within 24 hours following hospital admission. 
A patient interview was undertaken by using a standard-
ized BPMH form. A thorough history of all regular pread-
mission medication use (prescription, over-the-counter, 
dietary supplements, vitamins, herbal preparations, par-
enteral nutrition) was taken and completed using other 
sources of information including previous hospital records 
(discharge summaries), examination of the medication vi-
als, review of a home medication list, caregiver interview, 
and/or communication with outpatient pharmacy and/
or general practitioner (GP). All available sources of infor-
mation used to obtain the BPMH were recorded. Further-
more, the BPMH included the information about relevant 
demographic and clinical data, experienced adverse drug 
events, social history, and understanding of preadmission 
medications and level of adherence. Patients’ level of un-
derstanding of their preadmission therapy was assessed 
as high, medium or low, depending on whether the pa-
tient could provide the name, dose, route, and frequency 
of the medication use and its intended indication (5). The 
BPMH was then compared to admission orders prescribed 
by physicians to detect possible medication discrepancies. 
To improve patient safety and prevent medication errors 
from occurring during the health care process, pharma-
cists communicated directly with physicians in order to 
clarify whether the observed therapy changes were inten-
tional or unintentional.
classification of unintentional medication discrepancies
Unintentional medication discrepancies without any clini-
cal rationale were considered medication errors (5) and 
were classified according to the type of discrepancy into 
one of following categories: drug omission or addition, 
substitution of a medication within the same pharmaco-
logical group, incorrect dose, incorrect frequency, or incor-
rect route of administration. All unintentional medication 
discrepancies were presented to the expert panel team 
consisting of a clinical pharmacist and a clinical pharma-
cologist. Medication discrepancies were discussed and 
classified by their potential to cause harm, according 
to the method developed by Cornish et al (3). Additional 
sources of patient information, such as previous discharge 
summaries and laboratory test results, were reviewed as 
needed. All disagreements were resolved and consensus 
was achieved. The degree of impact of each medication 
discrepancy was defined as follows: a) class 1 – discrepan-
cies unlikely to cause patient discomfort or clinical deterio-
ration, b) class 2 – discrepancies with the potential to cause 
moderate discomfort or clinical deterioration, and c) class 
3 – discrepancies with the potential to result in severe dis-
comfort or clinical deterioration (3).
outcome measures and data collection
The primary outcome measure included the frequency, 
type, and potential severity of unintentional medication 
discrepancy derived by comparison of physicians’ admis-
sion medication orders and BPMH obtained by clinical 
pharmacists. To identify the predictors of unintentional 
medication discrepancies, the data collected in the pres-
ent study were patient demographic factors (age, sex, 
educational level, employment status, residence, type of 
hospital admission); clinical characteristics (comorbidities, 
readmission medication, history of adverse drug events, re-
cent hospitalization, length of hospital stay); and level of 
patients’ understanding of preadmission medication.
Statistical analysis
We used descriptive statistics to analyze patient charac-
teristics and collected data. Multivariate logistic regression 
analysis was used to determine the association between 
patient demographic and clinical characteristics and un-
intentional medication discrepancies. All analyses were 
performed using PSPP version 0.9.0 (Free Software Foun-
dation, Inc. Boston, MA, USA), a free software for statistical 
computing and graphics (28). Study results were consid-
ered significant at P < 0.05.
reSultS
Study sample
Of 8726 patients admitted to the Clinical Department of 
Internal Medicine during the study period, 423 (4.8%) pa-
tients were randomly selected. Among the selected pa-
tients, 12 of 423 were excluded as they refused to provide 
their informed consent. Thus, the final study population in-
cluded 411 patients. The mean age of the participants was 
65 years (19-92 years) with around 50% of male participants 
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(Table 1). Participants used six home prescription medica-
tions on average and had around five comorbidities.
Sources of information for BPMh
Interviews on medicine use were conducted by two study 
pharmacists and completed for all 411 participants. Infor-
mation provided by the standardized interview was com-
pared with other sources of information, which included 
previous medical records (79.3%), examination of medica-
tion vials (38.7%), communication with a GP (38.7%), pa-
tient’s own medication list (8%), family/caregiver interview 
(6.6%), and communication with a community pharmacy 
(0.2%). Pharmacists assessed a mean of 2.7 information 
sources per patient to obtain the accurate and complete 
BPMH. The mean time for the completion of pharmacists’ 
chart reviews, patient/caregiver interviews, and filling out 
BPMHs was 20 minutes per patient.
unintentional medication discrepancies
Overall, 1200 cases of medication discrepancies were iden-
tified, with 998 (83.2%) of them being intentional and 202 
(16.8%) unintentional. The overall rate of unintentional medi-
cation discrepancies was 0.48 per patient; 148 (35%) patients 
had one or more unintentional medication discrepancies. 
Twenty-six percent of all study participants had one, 7.1% 
had two, and 2.9% had three or more unintentional medica-
tion discrepancies. The most frequent type of unintentional 
medication discrepancy was an omission of essential thera-
py followed by an incorrect dose (Table 2). According to the 
potential severity of unintentional medication discrepancies, 
around 60% were assessed as having the potential to cause 
moderate or severe discomfort or clinical deterioration (Table 
2). Discrepancies with the potential to cause severe discom-
fort or clinical deterioration are detailed in Table 3. The three 
most frequent drug classes involved in unintentional discrep-
ancies according to the ATC classification included cardiovas-
cular system, nervous system, and gastrointestinal system (Ta-
taBle 1. Patient baseline demographics and clinical charac-




Mean age (range, years)   65 (19-92)
≥65  211 (51.3)
46-64  161 (39.2)
<45   39 (9.5)
Sex
male  220 (53.5)
educational level
no school or elementary school  134 (32.6)
high school  215 (52.3)
undergraduate   62 (15.1)
residence
living alone   59 (14.4)
living with family/caregiver  346 (84.2)
nursing home    6 (1.4)
admission to hospital
emergency  273 (66.4)
elective  138 (33.6)
Mean number of comorbidities (range)    4 (0-19)
Mean hospital length of stay (range, days)    9 (2-32)
Mean number of regular prescription home 
medications (BPMH*) (range)
   6 (1-19)
the most common drug classes in BPMh 
(atc† groups)
A alimentary tract and metabolism  545 (20.7)
B blood and blood forming organs  243 (9.2)
C cardiovascular system 1065 (40.5)
M musculo-skeletal system  130 (4.9)
N nervous system  315 (12.0)
R respiratory system  127 (4.8)
*Best Possible Medication history (BPMh).
†anatomical therapeutic chemical (atc) drug classification system.
taBle 2. types and potential severity of unintentional medication discrepancies in patients
number (%) of unintentional Potential severity of unintentional medication discrepancies (n,%)
type of medication discrepancy medication discrepancies class 1* class 2† class3*‡
Drug omission 129 (63.9) 43 (33.3) 53 (41.1) 33 (25.6)
Incorrect dose  49 (24.2) 32 (65.3) 13 (26.5)  4 (8.2)
Drug commission  17 (8.4)  2 (11.8)  6 (35.3)  9 (52.9)
Incorrect frequency   4 (2.0)  3 (75.0)  1 (25.0)  0 (0)
Drug substitution   3 (1.5)  1 (33.3)  1 (33.3)  1 (33.3)
Incorrect route   0  0 (0)  0 (0)  0 (0)
Total 202 81 (40.1) 74 (36.6) 47 (23.3)
*discrepancy had no potential to result in discomfort or clinical deterioration.
†discrepancy had the potential to result in moderate discomfort or clinical deterioration.
‡discrepancy had the potential to result in severe discomfort or clinical deterioration.
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ble 4). In addition, medicines used in the treatment of benign 
prostatic hypertrophy and chronic gout were often omitted.
association between patient characteristics and 
unintentional medication discrepancies
The association between patient characteristics and the 
likelihood of unintentional medication discrepancy was 
assessed in a multivariable model (Table 5). No significant 
associations were found for the age, sex, educational level, 
residence, type of hospital admission (elective vs emergen-
cy admission), outpatient visits in the prior year, previous-
ly experienced adverse drug events, number of comor-
bidities, and length of hospital stay. Increased number 
of preadmission medications (OR 1.19; 95% CI, 1.10-1.29, 
P < 0.001) was found to be the strongest predictor of unin-
taBle 3. examples of unintentional medication discrepancies with the potential to cause severe discomfort or clinical deterioration 
in patients (class 3)
Medication discrepancy
reason for hospital admission type description
Polypus colonis Drug omission Patient reported use of warfarin 1.5 mg/d before admission, which was not ordered on 
admission.
Pancreatic duct stones Drug addition Patient was taking tramadol p.o. 100 mg/d at home. After being admitted to the hospi-
tal, without the physician’s knowledge, the patient continued to use tramadol from his 
own supply while being treated with tramadol s.c. 50 mg/d.
Abdominal pain Drug addition Amoxicillin and clavulanate was initiated although the patient reported allergy to 
amoxicillin.
Atrial fibrillation Drug dose Theophylline, 400 mg twice daily, was initiated in a patient older than 65 years.
Pyrexia Drug 
substitution
Osveral 500 mg (Deferasirox) was ordered on admission, based on physician’s assump-
tion, instead of Osvaren 435 mg/235 mg (calcium acetate and magnesium carbonate).
Hypertension Drug dose Amlodipine, 20 mg/d, was ordered at admission (exceeding the maximum dose). Patient 
reported use of amlodipine 10 mg/d.
Rectal bleeding Drug addition Clarithromycin 500 mg was initiated without any indication.
Lung cancer Drug addition Ipratropium was initiated in therapy already containing tiotropium.
taBle 4. the most frequent medication groups and their therapeutic subgroups susceptible to unintentional medication discrep-
ancy, presented according to the anatomical therapeutic chemical (atc) classification
anatomical therapeutic chemical (atc) classification code number (%) of unintentional medication discrepancies
C (Cardiovascular system) 51 (25.2)
C01 Cardiac therapy  6
C02 Antihypertensive  3
C03 Diuretics  7 
C07 Beta blocking agents  8
C08 Calcium channel blockers  4
C09 Agents acting on the renin-angiotensin system 11
C10 Lipids modifying agents 12
N (Nervous system) 47 (23.3)
N02 Analgesics  8
N03 Antiepileptics  1
N04 Anti-Parkinson drugs  3
N05 Psycholeptics 30
N06 Psychoanaleptics  5
A (Alimentary tract and metabolism) 46 (22.8)
A02 Drugs for acid related disorders 22
A05 Bile and liver therapy  2
A07 Antidiarrheals, intestinal anti-inflammatory/anti-infective agents  3
A10 Drugs used in diabetes  6
A11 Vitamins  6
A12 Mineral supplements  7
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tentional medication discrepancies. Each additional medi-
cation increased the odds for the patient experiencing at 
least one medication error by 19%. Low level of patients’ 
understanding of preadmission medications was signifi-
cantly associated with unintentional medication discrep-
ancies (OR 1.79, 95% CI, 1.01-3.16, P = 0.046), although the 
odds ratio confidence interval was rather wide (1.01-3.16).
dIScuSSIon
Summary key findings and comparison with published 
studies
Clinical pharmacists in our study detected a high number 
of medication discrepancies, many of which were assessed 
as having the potential to cause severe discomfort or clini-
cal deterioration in patients. These results confirmed that 
clinical pharmacists are important in both detection and 
prevention of medication errors and correspond to the 
findings of previous studies on pharmacists’ role in med-
ication reconciliation (6-8,12,13) and a recent systematic 
review showing that pharmacist-led medication reconcil-
iation programs are a promising strategy for safe patient 
transitions (19). In addition, our study provided the first 
evidence on the discontinuity of care at the point of hos-
pital admission and is the first to assess its impact on pa-
tient care process in a clinical setting in Croatia. Moreover, 
to the best of our knowledge, this study is among the first 
studies conducted in South-Eastern European countries to 
have evaluated the incidence and potential clinical impact 
of unintentional medication discrepancies, thus contribut-
ing to the evidence base regarding the safety of seamless 
pharmaceutical patient care (29).
The incidence of unintentional medication discrepancies 
in the published literature varies considerably depending 
on the hospital setting including surgery, internal medi-
cine, geriatric or emergency departments (9,12,13,30). A 
higher proportion reported in the published data (3-5) 
could partially be explained by a less rigorous methodol-
taBle 5. risk factors for unintentional medication discrepancies
Patient characteristic P-value* odds ratio (95% confidence interval)
age 0.510 1.01 (0.99-1.02)
Sex
male 0.782 0.94 (0.60-1.47)
female Ref
education level
no school or elementary school 0.507 1.30 (0.60-1.47)
high school 0.789 1.10 (0.53-2.29)
community college 0.901 1.09 (0.27-4.47)
undergraduate Ref
type of residence
living alone 0.478 0.49 (0.07-3.48)
living with family, caregiver 0.206 0.29 (0.04-1.96)
nursing home Ref
admission
unplanned 0.185 0.71 (0.43-1.18)
planned Ref
Patient’s understanding of preadmission medications
low 0.046 1.79 (1.01-3.16)
medium 0.417 1.26 (0.72-2.22)
high Ref
history of ades† 0.800 1.06 (0.67-1.67)
recent hospitalization 0.366 0.81 (0.51-1.28)
number of comorbidities 0.211 0.95 (0.87-1.03)
length of hospital stay 0.223 1.03 (0.98-1.07)
number of medications (BPMh‡) <0.001 1.19 (1.10-1.29)
*Multiple logistic regression.
†adverse drug event.
‡Best Possible Medication history.
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ogy, ie, the use of outcome measures not differentiating 
between medication history-taking errors and reconcilia-
tion errors, or simply by the fact that more unintentional 
medication discrepancies were present and consequently 
captured in those study samples. In our study, only unin-
tentional medication discrepancies confirmed by hospi-
tal physicians were considered to be medication errors. 
Our results are comparable to the findings of studies per-
formed on general medical wards and those that used a 
methodology similar to ours. Gleason et al found over one-
third of patients having a medication error at admission (6), 
while Quélennec et al (8) demonstrated similar results with 
a third of patients having one or more unintentional medi-
cation discrepancies in a sample of 256 general medicine 
inpatients.
The most common type of unintentional medication dis-
crepancy in our study was the omission of pre-admission 
regular therapy, followed by an incorrect dose, which is 
similar to previous research findings (6,8,30,31). Major-
ity of unintentional medication discrepancies were found 
for cardiovascular agents and drugs acting on nervous 
and gastrointestinal system, which is consistent with find-
ings of other studies (5,6,8). Moreover, psycholeptic drugs 
(N05), namely benzodiazepines, were the most frequent 
therapeutic subgroup associated with unintentional medi-
cation discrepancies. They were often omitted and abrupt-
ly discontinued, possibly leading to withdrawal adverse 
effects, or needlessly introduced during hospital stay. Med-
ications to treat patients’ comorbidities, such as gout and 
functional symptoms of benign prostatic hyperplasia, were 
often overlooked, most probably due to polypharmacy in 
these patients and/or the complexity of the remaining 
medication regimen.
Each unintentional medication discrepancy was assessed 
for its potential harmfulness and severity. In our study, 
over half of the identified unintentional medication dis-
crepancies had the potential to cause moderate to severe 
discomfort or clinical deterioration (Classes 2 and 3). The 
incidence of unintentional, potentially harmful medica-
tion discrepancies found in the literature varies substan-
tially (3,6,10,32,33). For the assessment of potential clinical 
severity, different classification methodologies are in use. 
Adjusted National Coordinating Council for Medication Er-
ror Reporting and Prevention Index (NCC MERP Index) syn-
thesizing errors into three categories was used in previous 
studies (6,8). Similarly, methodology used in our study 
also classified medication errors in three categories 
where the first class had no potential to cause harm. 
However, the standard for evaluating the potential sever-
ity of unintentional medication discrepancies has not yet 
been established and it is, therefore, not possible to make 
a valid comparison between various studies.
clinical pharmacists-led medication reconciliation and 
other solutions
We found that around 60% of clinically significant medi-
cation discrepancies had the potential to threaten patient 
safety. It is a considerable incidence, which should be de-
tected and prevented. Therefore, the role of clinical phar-
macists in identifying medication discrepancies is of nota-
ble importance and considerable efforts need to be taken 
to strengthen their position in a medication reconciliation 
process and health care system in general. Practices in oth-
er countries have clearly demonstrated that it is feasible, 
time-saving, and cost-effective to include other health 
care providers, such as pharmacy technicians, pharmacy 
or medical students, in a medication reconciliation process 
(14,34). It increases the time available to the pharmacist for 
resolving drug therapy problems and allows them to pro-
vide more in-depth clinical services (35). Furthermore, in 
the Netherlands, pharmacy technicians play an important 
role in obtaining BPMH after being trained and under the 
supervision of hospital pharmacists. Studies conducted in 
Dutch hospitals demonstrated that pharmacy technicians 
could be successfully assigned to medication reconcilia-
tion process, because BPMH obtained by pharmacy tech-
nicians was comparable to that obtained by pharmacists 
when examining the mean number of discrepancies per 
patient (14,36). However, in addition to obtaining BPMH, 
medication reconciliation process used in our study in-
cluded intervening and rectifying medication errors by 
consultation with physicians when needed. It required a 
more complex skill mix from involved health care profes-
sionals, ie, clinical pharmacists. Moreover, our goal was to 
empower pharmacists, accentuate their unique role as 
medicine experts, and finally employ them as accessible 
workforce in the hospital. In addition, a position of pharma-
cy technicians in Croatia is unsatisfactory due to workload 
shortages. Their number is still undersized and their com-
petencies are neither recognized nor defined.
Pharmacists are the only health care professionals who 
do not have direct patient care responsibilities. Although 
clinical pharmacy services are delivered in inpatient en-
vironment and the pharmacist works “closely” with the 
physician, it is the physician or the nurse who still as-
sumes ultimate responsibility for most decisions or rec-
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ommendations made by the pharmacist. Therefore, in an 
attempt to start applying professional patient care prac-
tice in the same manner and according to the standards 
required from other health professionals, the advantage 
was given to pharmacists rather than pharmacy techni-
cians or nurses.
Other potential solutions for increasing patient safety in-
clude electronic medication reconciliation tools (11). Pre-
vious research explored the effect of an electronic medi-
cation reconciliation application combined with process 
redesign on decreasing medication discrepancies with 
potential for harm. The study results revealed a significant 
reduction in unintentional medication discrepancies with 
potential for harm (11). Still, there were problems associ-
ated with incomplete and inaccurate electronic sources 
of ambulatory medications and the fact that many hos-
pitals had not developed computerized provider order 
entry (CPOE) needed for computerized medication rec-
onciliation.
Patients should be encouraged to play a more active role 
during care transitions, when serious quality deficien-
cies happen. Patients and their family caregivers, being 
the main source of information, should be more actively 
involved through medication self-management, patient-
centered record, follow-up and red flag interventions, to 
improve quality and safety during care transitions. Previ-
ous evidence demonstrated that prompting patients to 
assume a more active role reduced hospitalization rates 
(37). In this study, pharmacists completed interview with 
all included patients or their caregivers and performed 
medication reconciliation in a thorough and extensive 
manner, while enabling them to assume a more active 
role by providing patients with various tools. Based on 
the level of patients’ understanding of their treatment 
and their adherence, they were educated properly about 
medications and the importance of taking medications 
regularly.
risk factors for unintentional medication discrepancies
We found two predictors of unintentional medication dis-
crepancies: an increased number of drugs and a low level 
of patients’ understanding of their home medications. Pre-
viously published studies have already confirmed the asso-
ciation between these two predictors and the occurrence 
of unintentional medication discrepancies (6,7,30). There-
fore, pharmacists should be focused on polypharmacy and 
a low level of therapy regimen understanding.
Study limitations
Our study had several limitations. First, it was conducted 
in a single Croatian hospital and the results may not be 
generalizable to other settings. Second, the rating meth-
od for potential severity of medication discrepancies has 
not been validated. However, methodology used in our 
study was strengthened by the fact that clinical pharma-
cists conducted the medication reconciliation process. The 
literature confirms that pharmacists identify more medica-
tions per patient than other health care professionals thus 
providing more accurate and complete medication histo-
ries (16,18). Consequently, more clinically relevant medica-
tion discrepancies of higher impact are identified through 
pharmacy-led medication reconciliation (19). Furthermore, 
pharmacists used a wide variety of sources of information 
and the data collection was very extensive, with a large 
number of demographic and clinical characteristics.
In conclusion, clinical pharmacist-led medication reconcili-
ation implementation program revealed a high rate of med-
ication errors in patients at hospital admission, with more 
than a half of them having the potential to cause moderate 
to severe discomfort or clinical deterioration, thus threat-
en patient safety. These results confirm that clinical phar-
macists play an important and invaluable role in detection 
of discrepancies and prevention of adverse patients’ out-
comes. Other hospitals can use the same methodology 
and implement clinical pharmacist-led medication recon-
ciliation at hospital admission. Since an increased number 
of drugs and a low level of patients’ understanding of pre-
admission therapy were found as predictors of medication 
errors, targeted patient education provided by pharma-
cists could render a feasible and sustainable solution.
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